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Diabetes and Breast Cancer Survivorship: A Case Report
The breast cancer survivor community continues to expand with improved breast cancer
screening and treatment. Female breast cancer survivors with a comorbid diagnosis of type 2
diabetes are at higher risk for morbidity, mortality and decreased quality of life than other breast
cancer survivors. A 45-year-old Caucasian female, with significant past medical history of type 2
diabetes and hypertension, presented to the primary care clinic for evaluation regarding diabetic
follow-up. She admitted to lack of follow-up regarding her diabetes, poor dietary choices and a
sedentary lifestyle. A collaborative approach was taken in the care of this patient to assure
improved outcomes and to reinforce necessary lifestyle changes. Survivorship care of diabetic
breast cancer survivors should focus on effective diabetes management, identification of
modifiable lifestyle factors, medication compliance and supporting positive health changes.
While additional research is required, future interventions must incorporative the entire treatment
team, including primary care providers and oncology specialists, in a coordinated effort to
improve breast cancer survivor quality of life and long-term outcomes. Lifestyle intervention
programs may help improve health-related quality of life in diabetic breast cancer survivors.
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Introduction
The continuous advancements in breast cancer screening and treatment coupled with an
aging society has resulted in a persistent expansion of the breast cancer survivor community
(Vissers, Falzon, van de Poll-Franse, Pouwer, & Thong, 2016). More than 3.5 million women in
the United States have are living with a history of breast cancer (American Cancer Society,
2017). The relative five-year survival rate for female breast cancer is near 90% with almost
100% 5-year relative survival rate for stage 1, localized, breast cancer (Howlander et al., 2017).
The incidence of type 2 diabetes in cancer survivors is higher than that of the general population
(Onitilo et al., 2013). Chronic conditions diagnosed in the cancer survivor are associated with
increased health care use, medical costs and loss of productivity (Guy et al., 2017; Heins,
Korevaar, Rijken & Schellevis, 2012). The purpose of this case report is to identify current
evidence regarding best practices in the care diabetic breast cancer survivors (BCS). This paper
will present necessary background information on the topic, a related case report, current
literature review, synthesis and recommendations for future research.
Background
In general, survivors of cancer are more likely to suffer from chronic conditions than an
individual without a history of cancer (Guy et al., 2017). Long-term cancer survivors are at
increased risk for type 2 diabetes, cardiovascular disease, overweight and obesity, chronic pain,
fatigue and poor health-related quality of life (Conlon et al., 2015). Unique considerations and
management interventions are required to improve survivorship care, including physical and
emotional heath promotion, in the growing population of BCS. While survivorship should be
much celebrated in the arena of breast cancer treatment, the long-term health, economic and
psychosocial implications must not be overlooked. The known long-term effects of the breast
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cancer diagnosis highlight the importance of improving survivorship care through intensified
screening, surveillance and chronic disease management (Guy et al., 2017).
While the community of cancer survivors continues to grow, finding a universally
accepted definition for the concept of “cancer survivorship” has proved difficult. For the purpose
of this case report, the content is directed towards the individual in “permanent survivorship”;
when cancer treatment is completed, recurrence is not likely and focus is on the long-term effects
of cancer and its treatment (American Society of Clinical Oncology, 2016). In addition, this case
report focuses on female BCS, recognizing these results may not be generalizable to male BCS.
While both cancer and diabetes share many similar risk factors including aging, obesity,
diet and physical inactivity, the association between the two disease states has yet to be fully
elucidated (Paxton, Taylor, Chang, Courneya, & Jones, 2013). Potential direct links between the
diagnosis of diabetes and cancer include hyperinsulinemia, hyperglycemia and inflammation
(Onitilo et al., 2013). The association may also be related to cancer treatment, age and/or
unhealthy lifestyle choices (obesity and sedentary lifestyle) (Onitilo et al., 2013; Lipscombe et
al., 2013; Weaver et al., 2013). Regardless, cancer survivors with diabetes represent a vulnerable
population who may benefit from increased screening and treatment of comorbidities, as well as
promoting a healthy lifestyle. A current review of the literature regarding the diagnosis of type 2
diabetes in BCS was conducted in order to identify best practices in providing survivorship care
to this patient population.
Case Report
A 45-year-old Caucasian female, with significant past medical history of type 2 diabetes
and hypertension, presented to the clinic for a chief complaint of “diabetes follow-up”. She
reported she saw the diabetes educator last week and was encouraged to come in for follow-up.
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She presented with concerns regarding a 20-pound weight gain over the course of a year and
fatigue for the last six months. She stated a known diagnosis of type 2 diabetes, however
admitted to being inconsistent in her follow-up for her diagnosis. She noted she was diagnosed
“a few years ago,” and at that time, she was started on oral Metformin 500 mg twice daily. She
reported taking this medication consistently. Family history was significant for a myocardial
infarction in her father at age 50.
In regards to her weight gain, the patient felt this was appropriate given her recent poor
dietary choices and inactivity. She denied any shortness of breath, edema or decreased urine
output. Her additional symptom of fatigue was quite nonspecific. Discussion included sleep
hygiene, limiting caffeine/alcohol intake as well as improving her glycemic control as
interventions to help with her symptoms of fatigue.
The patient’s vital signs revealed moderate hypertension at 148/98, a normal pulse,
respiratory rate and temperature. Her medications included Metformin 500 mg twice daily,
aspirin 81 mg daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily and a multivitamin. Upon
further questioning, she reported she stopped taking her Lisinopril “a while ago” due to the
commonly experienced side effect of cough. Otherwise, the patient was medication compliant.
Physical exam was benign, with the exception of some new onset of bilateral decreased sensation
to her feet. She denied any pain, numbness or tingling with this new onset neuropathy.
Laboratory tests performed included hemoglobin A1c, basic metabolic panel, thyroid stimulating
hormone, free t4 and lipid panel. Hemoglobin A1c was elevated at 8.5, and other results were
within expected limits.
These results were reviewed with the patient. This patient required improved blood
pressure management, and thus was started on an angiotensin receptor blocker in hopes to avoid
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the symptoms of cough she was experiencing. She also required intensified management of her
diabetes. She was instructed to increase her Metformin from 500 mg twice per day to 1000 mg
twice per day. She was instructed to continue her statin medication as well as a baby aspirin. She
was in agreement with this plan.
The patient was also advised to follow-up with the diabetic educator and dietician. She
has multiple areas for improvement in her lifestyle behaviors that could result in improved
diabetes management and decrease in cardiovascular risk. The patient was educated generally on
the importance of following a diabetic diet and incorporating activity into her daily routine. She
has historically not followed through with routine diabetic follow-up appointments. She is
educated on the need to be seen on a consistent basis in order to assure glycemic control,
medication compliance and maintenance of healthy lifestyle changes.
Literature Review
Optimal long-term management of type 2 diabetes in BCS requires the identification of
best practices, risk factors and interventions specific to this unique population. A literature
review was completed in order to help guide survivorship care, as well as identify areas of
opportunity for further study. A literature review was conducted using Cochrane Database of
Systematic Reviews (CDSR), CINAHL and PubMed databases.
The Cochrane Database of Systematic Reviews (CDSR) was searched first as these
reviews are considered to have a very strong level of evidence, with well-designed studies and
rigorous research. The CDSR was searched with the terms breast cancer (27370) AND survivor
(2862) AND diabetes (52707) resulting in 34 articles to review. Of the 34 results, 17 were
Cochrane reviews, none of which discussed diabetes in breast cancer survivorship. The
remaining 17 articles were trials; none of which were relevant for review on this topic.
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A search using similar terms was conducted on the PubMed database. The three Mesh
terms utilized in the search were survivor AND breast neoplasm AND diabetes mellitus resulting
in 11 articles to review. The search was limited to articles within the last 5 years. Of the 11
results, 10 were applicable for review.
Lastly, a search of Cumulative Index to Nursing and Allied Health Literature (CINAHL)
was completed. The search terms included were breast cancer AND diabetes AND survivor.
Initial search resulted in 48 articles for review. The search was limited to publications within the
last 5 years and peer-reviewed articles. This narrowed the search to 22 articles. Of the 22 articles,
4 were identified as duplicate results from the PubMed search. Of the remaining 18 articles, 7
were identified as pertinent to this literature review.
Research regarding the connection between cancer and diabetes has focused largely on
cancer incidence and mortality (Vissers et al., 2016). Connor et al. (2016) found that diabetes
was a prognostic indicator for all-cause and breast cancer specific mortality among BCS. While
preexisting diabetes does have an association with increased morbidity and mortality in cancer,
there is no evidence to suggest that the incidence of cancer has an adverse effect on the longterm outcomes of patients with diabetes (Griffiths et al., 2017). Much of the existing research
regarding diabetes in BCS has been focused on various cardiovascular risk factors with diabetes
as an included variable. Other research has focused on cancer survivors, in general, with BCS as
a subgroup.
Weaver et al. (2013) found that cardiovascular risk factors (such as body mass index,
physical inactivity, hypercholesterolemia, hypertension, and diabetes) were more common
among cancer survivors than the general adult population. In another study, diabetes and obesity
at age 30 were significantly associated with all-cause mortality in all female BCS (Connor et al.,
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2016). Onitilo et al. (2013) provided additional evidence of increased rates of vascular risk
factors such as kidney disease, heart disease and high blood pressure in BCS and patients with
diabetes; suggesting the possibility of a “double-hit” in BCS with diabetes. In a study conducted
regarding the effect of cardiovascular risk factors on long-term prognosis in BCS over the age of
65, cardiovascular risk factors such as very old age, smoking history, diabetes and hypertension
were more predictive of CVD risk than breast cancer history alone (Haque et al., 2014).
Additionally, Qin, Thompson and Silverman (2015) recommended the need for tight glycemic
control and longer monitoring for cardiac toxicity in diabetic BCS who have received
anthracycline chemotherapy (a commonly utilized agent in the treatment of breast cancer). The
BCS with diabetes proved to be at increased risk for late onset anthracycline-induced heart
failure than BCS without diabetes (Qin et al., 2015). Much improvement could be made to
improve the overall cardiovascular risk in diabetic BCS with interventions targeting modifiable
risk factors such as smoking, sedentary lifestyle and obesity.
A systemic review found patients with both cancer and diabetes diagnoses scored lower
on general health-related quality of life, physical functioning and sexual functioning than those
diagnosed with cancer or diabetes alone (Vissers et al., 2016). Tang et al. (2016) and Jarvandi,
Perez, Schootman and Jeffe (2016) concluded that a comorbid diagnosis of diabetes specifically
in BCS was associated with decreased quality of life in comparison to BCS without diabetes.
Cumulatively, the literature demonstrates enhanced cardiovascular assessment, optimized
diabetes management as well as interventions to promote positive lifestyle changes in the BCS
population are necessary to improve long term patient outcomes and quality of life.
Some consideration has been taken to analyze possible ethnic differences among diabetic
BCS. African-American and Hispanic/Latino cancer survivors are more than twice as likely to
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have comorbidities related to obesity, such as cardiovascular disease and diabetes, than whites
(Conlon et al., 2015). Ashing, Rosales, Lai & Hurria (2014) examined the occurrence of
comorbidities among African-American and Latina BCS, with 19% of the sample size endorsing
a diabetes diagnosis. Chronic conditions, such as diabetes, have been associated with increased
risk of poor health outcomes among Latina BCS (Ashing et al., 2014). Appropriate and timely
assessment and management of comorbid conditions in cancer survivors has important
implications on survival and quality of life (Ashing et al., 2014).
Paxton et al. (2013) determined African American BCS have higher rates of comorbid
conditions, such as diabetes, exacerbated by lack of physical activity and increased sedentary
behavior. There is a need for intervention focused research to assist African American BCS in
adopting and maintaining a physical active lifestyle after treatment (Paxton et al., 2013), as well
as further investigate how this unique population can be best supported after treatment
(Barsevick et al., 2016). In response to these findings, Black et al. (2018) completed a qualitative
study in attempts to identify barriers to physical activity in African-American BCS. In order to
achieve their physical activity goals after treatment, survivors require a multidisciplinary team to
assist with their psychosocial needs in addition to their physical limitations.
A first of its kind, the Bronx Oncology Living Daily (BOLD) Health Living program was
designed to help cancer survivors prevent and control diabetes. In areas of low socioeconomic
status, there is limited information and access to cancer screening, treatment and treatment
options. This intervention was directed towards an underserved community of cancer survivors
with limited resources to reduce comorbid risk. This short-term lifestyle intervention program for
cancer survivors was successful in improving health related quality of life and motivating
participants to improve health behaviors (Conlon et al., 2015). These results are promising
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evidence to support additional study into effective lifestyle intervention programs aimed at
improving health status and reducing comorbidity in BCS.
Medication compliance in breast cancer survivorship remains a concerning topic. BCS
have an increased use of long-term medications after the completion of cancer treatment (Loh,
Ng, Lee, Ng & Chan, 2016). Unfortunately, Yang, Neugut, Wright, Accordino and Hershman
(2016, p. e802) found that adherence to diabetes medication declined fro 79% to 53.1% in the
first year after breast cancer treatment. Additional research completed by Calip, Elmore and
Boudreau (2017) found that 75% of BCS studied were nonadherent in taking prescribed diabetic
medication. Nonadherence to medications prescribed for chronic conditions is associated with
increased all-cause mortality, health care cost and hospitalizations (Calip et al., 2017).
Development of evidence-based interventions to enhance medication adherence, specifically in
the diabetic BCS population, remains an area of opportunity for additional high-quality research
(Calip et al., 2017; Loh et al., 2016).
Prior research on medication adherence suggests interventions such as collaboration with
other healthcare providers, assistance with the cost of medications, promoting social support and
using technology-basted strategies may be successful (Yang et al., 2016). Close collaboration
between oncology and primary care providers in necessary for effective medication management
for BCS (Loh et al., 2016). In the future, the development of interventions to address noncancer
medication adherence after breast cancer treatment should be aimed at mediating factors
associated increased nonadherence such as older age, insurance type, polypharmacy, and more
comorbid conditions (Yang et al., 2016). Additional research is required to determine what
interventions would be the most beneficial for this population (Loh et al., 2016; Yang et al.,
2016).
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Throughout the literature there are some common themes regarding the increased
incidence of cardiovascular risk factors in cancer survivors (Connor et al., 2016; Qin et al., 2015;
Weaver et al., 2013), the importance intervention to reduce risk through modifiable lifestyle
factors (Conlon et al., 2015, Paxton et al., 2013), identifying ethnic and socioeconomic variations
in management (Ashing et al., 2014; Barsevick, 2016), and improving medication adherence of
BCS with type 2 diabetes (Calip et al., 2017; Loh et al., 2016; Yang et al., 2016). While unique
needs of BCS with diabetes have been identified, gaps remain in establishing evidence-based
interventions targeted towards risk reduction and management in this patient population.
In a study examining how frequently health care providers were counseling cancer
survivors with one or more cardiovascular risk factors, only a third of survivors reported having
a discussion with their healthcare provider regarding health promotion topics such diet, exercise
and lifestyle change (Weaver et al., 2013). Valid research continues to demonstrate the
importance of managing preexisting conditions in BCS (Haque et al., 2014). As discussed
previously, BCS with diabetes require intensified management of comorbid diagnoses. Many
BCS have modifiable cardiovascular risk factors that need to be addressed. An intervention to
increase the number of health promotion discussions occurring with diabetic BCS may be an
important area of further study.
The BOLD Healthy Living program offered evidence to support lifestyle intervention
programs to assist cancer survivors in prevention and control of diabetes (Conlon et al., 2015).
Implementation of a program with a similar curriculum in diabetic BCS may have similar
positive results. Development of interventions that coordinate the entire patient care team in the
management of comorbidities (Ashing et al., 2014) as well as research regarding mental health
issues, patient empowerment and improving patient self-management of chronic illness may be
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areas for further study to improve survivorship care in diabetic BCS (Vissers et al., 2016).
Learning Points
•

Survivorship care of diabetic BCS should focus on effective diabetes management
(Hauge et al., 2014), identification of modifiable problems (i.e. obesity, inactivity)
(Barsevick, 2016; Paxton et al., 2013) and supporting positive health changes (Onitilo et
al., 2013; Weaver et al., 2012).

•

Interventions must incorporative a multidisciplinary treatment team, including primary
care physicians and oncology specialists, in a coordinated effort to improve management
of comorbidities in cancer survivors (Ashing et al., 2014).

•

Special consideration for high-risk populations, such as ethnic minorities and low
socioeconomic classes, could aide in identifying barriers to healthy behaviors and
individualize health promotion recommendations (Ashing et al., 2014; Barsevick, 2016;
Conlon et al., 2015; Black et al., 2018; Paxton et al., 2013).

•

Lifestyle intervention programs may help improve health-related quality of life in
diabetic BCS (Conlon et al., 2015).

•

Interventions to improve medication compliance in diabetic BCS could improve overall
outcomes (Loh et al., 2016; Yang et al., 2016).
Conclusion
Improvement in screening, diagnosis and treatment of breast cancer in women has lead to

an increase in the BCS population. BCS with diabetes are more likely to suffer from increased
morbidity, mortality, and decreased health-related quality of life than BCS without diabetes
(Barsevick et al., 2016; Jarvancdi et al., 2016; Tang et al., 2016; Vissers et al., 2016). Diabetic
BCS face unique physical and emotional difficulties in their survivorship journey. BCS with
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diabetes require individualized support and early risk-factor identification, screening and disease
management. Further research into interventions specifically regarding emotional and
multidisciplinary support for sustaining healthy lifestyle change and medication adherence in
BCS with diabetes, not only could improve morbidity, mortality and quality of life, but also
stands to enhance survivorship care for this growing population.
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